Interferon alfa-2a Completed Phase 2 Trials for Nephroid Carcinoma / Adenocarcinomas / Carcinoma NOS / Renal Cell / Hypernephroid Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00719264Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer